T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Alpha Pro Tech
APT
$54.8M
| $85K | ﹤0.01% |
16,000
| – | – |
|
2852
Definitive Healthcare
DH
$69.4M
| $85K | ﹤0.01% |
20,572
+3,496
| +20% | +$15.3K |
|
|
NXDT
2853
NexPoint Diversified Real Estate Trust
NXDT
$250M
| $85K | ﹤0.01% |
13,916
+2,641
| +23% | +$15.5K |
|
|
ONL
2854
Orion Office REIT
ONL
$161M
| $85K | ﹤0.01% |
22,764
+3,976
| +21% | +$15.6K |
|
2855
AerSale
ASLE
$269M
| $84K | ﹤0.01% |
13,277
+2,665
| +25% | +$15.3K |
|
|
EWCZ
2856
DELISTED
European Wax Center
EWCZ
| $84K | ﹤0.01% |
12,452
+1,582
| +15% | +$10.4K |
|
|
SLRN
2857
DELISTED
ACELYRIN
SLRN
| $84K | ﹤0.01% |
26,738
+3,266
| +14% | +$15.8K |
|
|
TTSH
2858
DELISTED
Tile Shop Holdings
TTSH
| $83K | ﹤0.01% |
+11,862
| New | +$79.1K |
|
2859
Kaltura
KLTR
$241M
| $81K | ﹤0.01% |
36,742
| – | – |
|
2860
Getty Images
GETY
$124M
| $80K | ﹤0.01% |
36,897
+4,826
| +15% | +$15.8K |
|
2861
Liberty Latin America Class A
LILA
$1.69B
| $80K | ﹤0.01% |
18,404
+2,093
| +13% | +$11.5K |
|
2862
Tredegar Corp
TG
$281M
| $80K | ﹤0.01% |
+10,376
| New | +$78.9K |
|
2863
Mammoth Energy Services
TUSK
$158M
| $80K | ﹤0.01% |
26,473
| – | – |
|
2864
Verastem
VSTM
$629M
| $80K | ﹤0.01% |
15,390
+129
| +0.8% | +$508 |
|
2865
Arq
ARQ
$100M
| $79K | ﹤0.01% |
+10,330
| New | +$67.9K |
|
2866
Absci
ABSI
$1.63B
| $77K | ﹤0.01% |
29,333
+3,747
| +15% | +$13.2K |
|
|
BGFV
2867
DELISTED
Big 5 Sporting Goods
BGFV
| $77K | ﹤0.01% |
42,900
| – | – |
|
2868
Design Therapeutics
DSGN
$917M
| $77K | ﹤0.01% |
12,451
+2,167
| +21% | +$12.5K |
|
2869
Biomea Fusion
BMEA
$92.8M
| $76K | ﹤0.01% |
19,352
+1,215
| +7% | +$9.68K |
|
2870
PLAYSTUDIOS Inc
MYPS
$67.3M
| $74K | ﹤0.01% |
39,525
+10,130
| +34% | +$17.4K |
|
2871
LanzaTech
LNZA
$67.1M
| $72K | ﹤0.01% |
523
+164
| +46% | +$24.6K |
|
2872
BRC Inc
BRCC
$215M
| $71K | ﹤0.01% |
22,233
+4,364
| +24% | +$13.6K |
|
2873
Heron Therapeutics
HRTX
$64.7M
| $71K | ﹤0.01% |
46,179
+8,684
| +23% | +$14.1K |
|
|
TPIC
2874
DELISTED
TPI Composites
TPIC
| $71K | ﹤0.01% |
37,404
| – | – |
|
2875
LifeMD
LFMD
$159M
| $70K | ﹤0.01% |
14,012
+2,895
| +26% | +$15.2K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.